SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

SMTL ID : 4yth.1

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Diseases

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.04 Å
Oligo State
monomer
Ligands
1 x 467: N~2~-[2-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]-2-methyl-N-(2,2,2-trifluoroethyl)-D-alaninamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Farmer, L.J. et al., Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases. J.Med.Chem. (2015)
Release Date
2015-08-12
Peptides
Tyrosine-protein kinase JAK2: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence

4ytc.1 | 4ytf.1 | 4yti.1